Venetoclax-based therapy for relapsed or refractory acute myeloid leukemia: latest updates from the 2022 ASH annual meeting.

Autor: Gong, Xubo1 (AUTHOR), Zhang, Yi2 (AUTHOR), He, Xin3 (AUTHOR), Moloudizargari, Milad3 (AUTHOR), Yu, Teng4 (AUTHOR), Wang, Lin1 (AUTHOR), Liu, Weiwei1 (AUTHOR), Jin, Lan1 (AUTHOR), Xu, Huiying1 (AUTHOR), Xu, Yang4 (AUTHOR) yxu@zju.edu.cn, Tao, Zhihua1 (AUTHOR) zrtzh@zju.edu.cn, Qian, Wenbin4 (AUTHOR) qianwb@zju.edu.cn
Zdroj: Experimental Hematology & Oncology. 6/30/2023, Vol. 12 Issue 1, p1-4. 4p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje